Model of end stage liver disease (MELD) score greater than 23 predicts length of stay in the ICU but not mortality in liver transplant recipients

Critical Care

Volumn 14, Issue 3, 2010, Pages

  Oberkofler, Christian E ^a   Dutkowski, Philipp ^a   Stocker, Reto ^a   Schuepbach, Reto A ^a   Stover, John F ^a   Clavien, Pierre Alain ^a   Béchir, Markus ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

FRESH FROZEN PLASMA;

ARTICLE; END STAGE LIVER DISEASE; ERYTHROCYTE TRANSFUSION; FEMALE; GRAFT RECIPIENT; HAZARD RATIO; HUMAN; INTENSIVE CARE UNIT; KIDNEY FAILURE; LENGTH OF STAY; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PLASMA TRANSFUSION; PRIORITY JOURNAL; RENAL REPLACEMENT THERAPY; RETROSPECTIVE STUDY; SURGICAL RISK; METHODOLOGY; MORTALITY; OUTCOME ASSESSMENT; PATHOPHYSIOLOGY; POSTOPERATIVE COMPLICATION; PREDICTIVE VALUE; PROGNOSIS; SWITZERLAND;

END STAGE LIVER DISEASE; FEMALE; HUMANS; INTENSIVE CARE UNITS; LENGTH OF STAY; LIVER TRANSPLANTATION; MALE; OUTCOME ASSESSMENT (HEALTH CARE); POSTOPERATIVE COMPLICATIONS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RETROSPECTIVE STUDIES; SWITZERLAND;

EID: 78651099602     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc9068     Document Type: Article

References (60)

1. Sagmeister M, Mullhaupt B. Is living donor liver transplantation cost-effective?. J Hepatol 2005, 43:27-32. 10.1016/j.jhep.2005.05.005, 15922477.
2. Sachdev M, Hernandez JL, Sharma P, Douglas DD, Byrne T, Harrison ME, Mulligan D, Moss A, Reddy K, Vargas HE, Rakela J, Balan V. Liver transplantation in the MELD era: a single-center experience. Dig Dis Sci 2006, 51:1070-1078. 10.1007/s10620-006-8011-1, 16865573.
3. Martin AP, Bartels M, Hauss J, Fangmann J. Overview of the MELD score and the UNOS adult liver allocation system. Transplant Proc 2007, 39:3169-3174. 10.1016/j.transproceed.2007.04.025, 18089345.
4. Ravaioli M, Grazi GL, Ballardini G, Cavrini G, Ercolani G, Cescon M, Zanello M, Cucchetti A, Tuci F, Del Gaudio M, Varotti G, Vetrone G, Trevisani F, Bolondi L, Pinna AD. Liver transplantation with the Meld system: a prospective study from a single European center. Am J Transplant 2006, 6:1572-1577. 10.1111/j.1600-6143.2006.01354.x, 16827857.
5. Tsui TY, Scherer MN, Schnitzbauer AA, Schlitt HJ, Obed A. Adult living donor liver transplantation: body mass index and MELD score of recipients are independent risk factors for hospital mortality. Langenbecks Arch Surg 2009, 394:235-241. 10.1007/s00423-008-0348-9, 18512070.
6. Organ Procurement and Transplantation Network. , http://www.optn.org
7. Ferraz-Neto BH, Zurstrassen MP, Hidalgo R, Meira-Filho SP, Rezende MB, Paes AT, Afonso RC. Analysis of liver transplantation outcome in patients with MELD Score > or = 30. Transplant Proc 2008, 40:797-799. 10.1016/j.transproceed.2008.03.016, 18455020.
8. Santoyo J, Suarez M, Fernandez-Aguilar J, Perez Daga J, Sanchez-Perez B, Ramirez C, Aranda J, Rodriguez-Canete A, Gonzalez-Sanchez A. True impact of the indication of cirrhosis and the MELD on the results of liver transplantation. Transplant Proc 2006, 38:2462-2464. 10.1016/j.transproceed.2006.08.015, 17097967.
9. Saner FH, Sotiropoulos GC, Radtke A, Fouzas I, Molmenti EP, Nadalin S, Paul A. Intensive care unit management of liver transplant patients: a formidable challenge for the intensivist. Transplant Proc 2008, 40:3206-3208. 10.1016/j.transproceed.2008.08.069, 19010236.
10. McGilvray ID, Greig PD. Critical care of the liver transplant patient: an update. Curr Opin Crit Care 2002, 8:178-182. 10.1097/00075198-200204000-00015, 12386521.
11. Saner F, Kavuk I, Lang H, Fruhauf NR, Paul A, Stavrou G, Malago M, Broelsch CE. Postoperative ICU management in liver transplant patients. Eur J Med Res 2003, 8:511-516.
12. Cholongitas E, Marelli L, Shusang V, Senzolo M, Rolles K, Patch D, Burroughs AK. A systematic review of the performance of the model for end-stage liver disease (MELD) in the setting of liver transplantation. Liver Transpl 2006, 12:1049-1061. 10.1002/lt.20824, 16799946.
13. Swiss National Foundation for organ donation and transplantation. , http://www.Swisstransplant.org
14. Adam R, Bismuth H, Diamond T, Ducot B, Morino M, Astarcioglu I, Johann M, Azoulay D, Chiche L, Bao YM, et al. Effect of extended cold ischaemia with UW solution on graft function after liver transplantation. Lancet 1992, 340:1373-1376. 10.1016/0140-6736(92)92559-X, 1360089.
15. Merion RM, Goodrich NP, Feng S. How can we define expanded criteria for liver donors?. J Hepatol 2006, 45:484-488. 10.1016/j.jhep.2006.07.016, 16905221.
16. Arroyo V, Gines P, Gerbes AL, Dudley FJ, Gentilini P, Laffi G, Reynolds TB, Ring-Larsen H, Scholmerich J. Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. International Ascites Club. Hepatology 1996, 23:164-176. 10.1002/hep.510230122, 8550036.
17. Salerno F, Gerbes A, Gines P, Wong F, Arroyo V. Diagnosis, prevention and treatment of hepatorenal syndrome in cirrhosis. Gut 2007, 56:1310-1318. 1954971, 17389705.
18. McCormack L, Selzner M, Clavien P-A. The transplant operation. Medical Care of Liver Transplantation 2006, 229-241. Oxford, England: Blackwell Publishing, Killenberg P, Clavien P-A.
19. Yantorno SE, Kremers WK, Ruf AE, Trentadue JJ, Podesta LG, Villamil FG. MELD is superior to King's college and Clichy's criteria to assess prognosis in fulminant hepatic failure. Liver Transpl 2007, 13:822-828. 10.1002/lt.21104, 17539002.
20. Siniscalchi A, Cucchetti A, Toccaceli L, Spiritoso R, Tommasoni E, Spedicato S, Dante A, Riganello L, Zanoni A, Cimatti M, Pierucci E, Bernardi E, Miklosova Z, Pinna AD, Faenza S. Pretransplant model for end-stage liver disease score as a predictor of postoperative complications after liver transplantation. Transplant Proc 2009, 41:1240-1242. 10.1016/j.transproceed.2009.02.046, 19460528.
21. Saab S, Wang V, Ibrahim AB, Durazo F, Han S, Farmer DG, Yersiz H, Morrisey M, Goldstein LI, Ghobrial RM, Busuttil RW. MELD score predicts 1-year patient survival post-orthotopic liver transplantation. Liver Transpl 2003, 9:473-476. 10.1053/jlts.2003.50090, 12740789.
22. Bazarah SM, Peltekian KM, McAlister VC, Bitter-Suermann H, MacDonald AS. Utility of MELD and Child-Turcotte-Pugh scores and the Canadian waitlisting algorithm in predicting short-term survival after liver transplant. Clin Invest Med 2004, 27:162-167.
23. Kremers WK, van IM, Kim WR, Freeman RB, Harper AM, Kamath PS, Wiesner RH. MELD score as a predictor of pretransplant and posttransplant survival in OPTN/UNOS status 1 patients. Hepatology 2004, 39:764-769. 10.1002/hep.20083, 14999695.
24. Narayanan Menon KV, Nyberg SL, Harmsen WS, DeSouza NF, Rosen CB, Krom RA, Wiesner RH. MELD and other factors associated with survival after liver transplantation. Am J Transplant 2004, 4:819-825. 10.1111/j.1600-6143.2004.00433.x, 15084180.
25. Kogure T, Ueno Y, Kawagishi N, Kanno N, Yamagiwa Y, Fukushima K, Satomi S, Shimosegawa T. The model for end-stage liver disease score is useful for predicting economic outcomes in adult cases of living donor liver transplantation. J Gastroenterol 2006, 41:1005-1010. 10.1007/s00535-006-1887-x, 17096070.
26. Chang T-J. Prognostic factors of postoperative ARF. Dialysis & Transplatation 1999, 29:114-123.
27. Faenza S, Santoro A, Mancini E, Pareschi S, Siniscalchi A, Zanzani C, Pinna AD. Acute renal failure requiring renal replacement therapy after orthotopic liver transplantation. Transplant Proc 2006, 38:1141-1142. 10.1016/j.transproceed.2006.02.151, 16757289.
28. Fraley DS, Burr R, Bernardini J, Angus D, Kramer DJ, Johnson JP. Impact of acute renal failure on mortality in end-stage liver disease with or without transplantation. Kidney Int 1998, 54:518-524. 10.1046/j.1523-1755.1998.00004.x, 9690218.
29. Uchino S, Kellum JA, Bellomo R, Doig GS, Morimatsu H, Morgera S, Schetz M, Tan I, Bouman C, Macedo E, Gibney N, Tolwani A, Ronco C. Acute renal failure in critically ill patients: a multinational, multicenter study. JAMA 2005, 294:813-818. 10.1001/jama.294.7.813, 16106006.
30. Cabezuelo JB, Ramirez P, Acosta F, Sanchez Bueno F, Robles R, Pons JA, Miras M, Munitiz V, Fernandez JA, Lujan J, Rodriguez JM, Bru M, Berenguer JJ, Parrilla P. Prognostic factors of early acute renal failure in liver transplantation. Transplant Proc 2002, 34:254-255. 10.1016/S0041-1345(01)02749-X, 11959271.
31. de Mendonca A, Vincent JL, Suter PM, Moreno R, Dearden NM, Antonelli M, Takala J, Sprung C, Cantraine F. Acute renal failure in the ICU: risk factors and outcome evaluated by the SOFA score. Intensive Care Med 2000, 26:915-921. 10.1007/s001340051281, 10990106.
32. Faenza S, Bernardi E, Cimatti M, Dante A, Mancini E, Miklosova Z, Piraccini E, Pierucci E, Riganello I, Spedicato S, Zanoni A, Santoro A. Acute renal failure after liver transplantation in MELD era. Transplant Proc 2007, 39:1945-1946. 10.1016/j.transproceed.2007.05.050, 17692661.
33. Biancofiore G, Davis CL. Renal dysfunction in the perioperative liver transplant period. Curr Opin Organ Transplant 2008, 13:291-297. 10.1097/MOT.0b013e328300a058, 18685320.
34. Gonwa TA, McBride MA, Anderson K, Mai ML, Wadei H, Ahsan N. Continued influence of preoperative renal function on outcome of orthotopic liver transplant (OLTX) in the US: where will MELD lead us?. Am J Transplant 2006, 6:2651-2659. 10.1111/j.1600-6143.2006.01526.x, 16939515.
35. Planinsic RM, Lebowitz JJ. Renal failure in end-stage liver disease and liver transplantation. Int Anesthesiol Clin 2006, 44:35-49. 10.1097/01.aia.0000210807.24298.f7, 16832205.
36. Cabezuelo JB, Ramirez P, Rios A, Acosta F, Torres D, Sansano T, Pons JA, Bru M, Montoya M, Bueno FS, Robles R, Parrilla P. Risk factors of acute renal failure after liver transplantation. Kidney Int 2006, 69:1073-1080. 10.1038/sj.ki.5000216, 16528257.
37. Shaw BW, Martin DJ, Marquez JM, Kang YG, Bugbee AC, Iwatsuki S, Griffith BP, Hardesty RL, Bahnson HT, Starzl TE. Venous bypass in clinical liver transplantation. Ann Surg 1984, 200:524-534. 10.1097/00000658-198410000-00013, 1250523, 6385876.
38. Shaw BW, Martin DJ, Marquez JM, Kang YG, Bugbee AC, Iwatsuki S, Griffith BP, Hardesty RL, Bahnson HT, Starzl TE. Advantages of venous bypass during orthotopic transplantation of the liver. Semin Liver Dis 1985, 5:344-348. 10.1055/s-2008-1040631, 3909428.
39. Gallardo M, Gutierrez M, Pérez G, Balsera E, Ortega J, Garcia G. Risk factors for renal dysfunction in the postoperative course of liver transplant. Liver Transpl 2004, 10:1379-1385. 10.1002/lt.20215, 15497160.
40. Ruiz R, Barri YM, Jennings LW, Chinnakotla S, Goldstein RM, Levy MF, McKenna GJ, Randall HB, Sanchez EQ, Klintmalm GB. Hepatorenal syndrome: a proposal for kidney after liver transplantation (KALT). Liver Transpl 2007, 13:838-843. 10.1002/lt.21149, 17539003.
41. Weismuller TJ, Prokein J, Becker T, Barg-Hock H, Klempnauer J, Manns MP, Strassburg CP. Prediction of survival after liver transplantation by pre-transplant parameters. Scand J Gastroenterol 2008, 43:736-746. 10.1080/00365520801932944, 18569992.
42. Ruiz R, Kunitake H, Wilkinson AH, Danovitch GM, Farmer DG, Ghobrial RM, Yersiz H, Hiatt JR, Busuttil RW. Long-term analysis of combined liver and kidney transplantation at a single center. Arch Surg 2006, 141:735-741. discussion 741-732, 10.1001/archsurg.141.8.735, 16924080.
43. Lo CM, Fan ST, Liu CL, Yong BH, Wong Y, Lau GK, Lai CL, Ng IO, Wong J. Lessons learned from one hundred right lobe living donor liver transplants. Ann Surg 2004, 240:151-158. 10.1097/01.sla.0000129340.05238.a0, 1356387, 15213631.
44. Marik PE, Wood K, Starzl TE. The course of type 1 hepato-renal syndrome post liver transplantation. Nephrol Dial Transplant 2006, 21:478-482. 10.1093/ndt/gfi212, 16249201.
45. Cherry T, Steciuk M, Reddy VV, Marques MB. Transfusion-related acute lung injury: past, present, and future. Am J Clin Pathol 2008, 129:287-297. 10.1309/D3F7BXH466AE3G0P, 18208810.
46. Klein HG, Spahn DR, Carson JL. Red blood cell transfusion in clinical practice. Lancet 2007, 370:415-426. 10.1016/S0140-6736(07)61197-0, 17679019.
47. Tinmouth A, Fergusson D, Yee IC, Hebert PC. Clinical consequences of red cell storage in the critically ill. Transfusion 2006, 46:2014-2027. 10.1111/j.1537-2995.2006.01026.x, 17076859.
48. de Rougemont O, Dutkowski P, Weber M, Clavien P-A. Abdominal drains in liver transplantation: useful tool or useless dogma? A match case-control study. Liver Transpl 2009, 15:96-101. 10.1002/lt.21676, 19109839.
49. Massicotte L, Lenis S, Thibeault L, Sassine MP, Seal RF, Roy A. Effect of low central venous pressure and phlebotomy on blood product transfusion requirements during liver transplantations. Liver Transpl 2006, 12:117-123. 10.1002/lt.20559, 16382461.
50. Nardo B, Bertelli R, Montalti R, Beltempo P, Puviani L, Pacile V, Cavallari A. Red blood cell transfusion in liver transplantation: a case-control study. Transplant Proc 2005, 37:4389-4392. 10.1016/j.transproceed.2005.11.030, 16387128.
51. Rueggeberg A, Boehm S, Napieralski F, Mueller AR, Neuhaus P, Falke KJ, Gerlach H. Development of a risk stratification model for predicting acute renal failure in orthotopic liver transplantation recipients. Anaesthesia 2008, 63:1174-1180. 10.1111/j.1365-2044.2008.05604.x, 18803627.
52. Smith JO, Shiffman ML, Behnke M, Stravitz RT, Luketic VA, Sanyal AJ, Heuman DM, Fisher RA, Cotterell AH, Maluf DG, Posner MP, Sterling RK. Incidence of prolonged length of stay after orthotopic liver transplantation and its influence on outcomes. Liver Transpl 2009, 15:273-279. 10.1002/lt.21731, 19243008.
53. McCormack L, Petrowsky H, Jochum W, Mullhaupt B, Weber M, Clavien PA. Use of severely steatotic grafts in liver transplantation: a matched case-control study. Ann Surg 2007, 246:940-946. discussion 946-948, 10.1097/SLA.0b013e31815c2a3f, 18043095.
54. Tector AJ, Mangus RS, Chestovich P, Vianna R, Fridell JA, Milgrom ML, Sanders C, Kwo PY. Use of extended criteria livers decreases wait time for liver transplantation without adversely impacting posttransplant survival. Ann Surg 2006, 244:439-450. 1856546, 16926570.
55. Candel FJ, Grima E, Matesanz M, Cervera C, Soto G, Almela M, Martinez JA, Navasa M, Cofan F, Ricart MJ, Perez-Villa F, Moreno A. Bacteremia and septic shock after solid-organ transplantation. Transplant Proc 2005, 37:4097-4099. 10.1016/j.transproceed.2005.09.181, 16386636.
56. Singh N, Paterson DL, Gayowski T, Wagener MM, Marino IR. Predicting bacteremia and bacteremic mortality in liver transplant recipients. Liver Transpl 2000, 6:54-61.
57. Angus DC, Wax RS. Epidemiology of sepsis: an update. Crit Care Med 2001, 29:S109-116. 10.1097/00003246-200107001-00035, 11445744.
58. Gurusamy KS, Kumar Y, Davidson BR. Systematic review on preventing bacterial sepsis and wound complications in liver transplant patients methods of preventing bacterial sepsis and wound complications for liver transplantation. Cochrane Database Syst Rev 2008, CD006660.
59. Dellinger RP, Carlet JM, Gerlach H, Ramsey G, Levy M. The surviving sepsis guidelines: not another "groundhog day". Crit Care Med 2004, 32:1601-1602. 10.1097/01.CCM.0000130996.14896.F6, 15241108.
60. Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM, Jaeschke R, Reinhart K, Angus DC, Brun-Buisson C, Beale R, Calandra T, Dhainaut JF, Gerlach H, Harvey M, Marini JJ, Marshall J, Ranieri M, Ramsay G, Sevransky J, Thompson BT, Townsend S, Vender JS, Zimmerman JL, Vincent JL. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Intensive Care Med 2008, 34:17-60. 10.1007/s00134-007-0934-2, 2249616, 18058085.